These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26119615)

  • 1. Clostridium difficile Relapse Secondary to Medication Access Issue.
    AORN J; 2015 Jul; 102(1):108, 63. PubMed ID: 26119615
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridium difficile infection: historic review.
    Bartlett JG
    Anaerobe; 2009 Dec; 15(6):227-9. PubMed ID: 19755167
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile bacteremia.
    Kaufman E; Liska D; Rubinshteyn V; Nandakumar G
    Surg Infect (Larchmt); 2013 Dec; 14(6):559-60. PubMed ID: 24111758
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of slowly resolving enteritis caused by Clostridium difficile].
    Zoppi G; Vinco A; Cinquetti M; Barbato G; Luciano A
    Pediatr Med Chir; 1995; 17(5):459-60. PubMed ID: 8685005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
    Tordjman R; Benfiguig K; Eugène C; Mitry E; Merrer J
    Gastroenterol Clin Biol; 1995 May; 19(5):545-6. PubMed ID: 7590012
    [No Abstract]   [Full Text] [Related]  

  • 9. Fidaxomicin for Clostridium difficile Infection.
    Safdar N; Craig WA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561360
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
    Sydnor ER; Lenhart A; Trollinger B; Avdic E; Maragakis LL; Carroll KC; Cosgrove SE
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1133-6. PubMed ID: 22011545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.
    Byker GL; Dinh MT; Gunaratnam NT; Robinson EA; Shehab TM; Malani AN
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):397-9. PubMed ID: 19239379
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of first recurrence of Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Treatment for Clostridium difficile Infection in Adults.
    Wilson A
    Am J Nurs; 2018 Jul; 118(7):63. PubMed ID: 29957645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment.
    Simon MS
    Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile].
    Nyc O
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):93-6. PubMed ID: 20640987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
    Jinno S; Kundrapu S; Guerrero DM; Jury LA; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):638-9. PubMed ID: 22561724
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 19. Fidaxomicin for Clostridium difficile infection.
    Linsky A; Gupta K; Hermos JA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
    Mathur T; Kumar M; Barman TK; Kumar GR; Kalia V; Singhal S; Raj VS; Upadhyay DJ; Das B; Bhatnagar PK
    J Antimicrob Chemother; 2011 May; 66(5):1087-95. PubMed ID: 21393140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.